Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ORIX Capital is the venture capital and private equity investment arm of ORIX Corporation, a global financial services group based in Japan. The firm is a significant player in the healthcare and life sciences investment landscape, providing capital and strategic support to companies developing innovative therapeutics, medical devices, and digital health solutions. ORIX Capital focuses on identifying high-growth opportunities within the biotechnology sector, leveraging its parent company's extensive network to facilitate market entry and expansion for its portfolio companies. The firm's investment strategy encompasses various stages of company growth, from early-stage venture rounds to later-stage private equity buyouts. Through its dedicated healthcare focus, ORIX Capital contributes to the advancement of medical technology and the commercialization of new treatments globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ORIX Capital.